Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Wilton

Showing results (91-100 of 106) with videos related to

Pageof 11
Sort By:
Hormone Research|January 1, 1995
Insulin-like growth factor I improves height in growth hormone insensitivity: two years' resultsM B Ranke, M O Savage, P G Chatelain, et al.
The Journal of Clinical Endocrinology and Metabolism|November 10, 2001
Healthcare consumption decreases in parallel with improvements in quality of life during GH replacement in hypopituitary adults with GH deficiencyE Hernberg-Ståhl, A Luger, R Abs, et al.
Acta Paediatrica Scandinavica. Supplement|January 1, 1988
Recombinant somatropin in treatment of growth hormone deficient children in Sweden and FinlandK Albertsson-Wikland, S Aronson, K O Nilsson, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 24, 2001
The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density. C Wüster, R Abs, B A Bengtsson, et al.
Annals of Internal Medicine|October 15, 1988
Distinguishing benign from malignant euadrenal massesM D Gross, B Shapiro, J A Bouffard, et al.
The Journal of Clinical Endocrinology and Metabolism|November 24, 1999
The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults. KIMS Study Group and the KIMS International BoardB A Bengtsson, R Abs, H Bennmarker, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1987
Functional and scintigraphic evaluation of the silent adrenal massM D Gross, G P Wilton, B Shapiro, et al.
Rheumatology International|July 3, 2014
Erratum to: The effects of an oral preparation containing hyaluronic acid (Oralvisc(®)) on obese knee osteoarthritis patients determined by pain, function, bradykinin, leptin, inflammatory cytokines, and heavy water analysesF R Nelson, R A Zvirbulis, B Zonca, et al.
Rheumatology International|June 6, 2014
The effects of an oral preparation containing hyaluronic acid (Oralvisc®) on obese knee osteoarthritis patients determined by pain, function, bradykinin, leptin, inflammatory cytokines, and heavy water analysesF R Nelson, R A Zvirbulis, B Zonca, et al.
Clinical Endocrinology|September 6, 2000
Growth hormone deficiency and replacement in elderly hypopituitary adults. KIMS Study Group and the KIMS International Board. Pharmacia and Upjohn International Metabolic DatabaseJ P Monson, R Abs, B A Bengtsson, et al.
Pageof 11

Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
Hormone Research|January 1, 1995
Insulin-like growth factor I improves height in growth hormone insensitivity: two years' resultsM B Ranke, M O Savage, P G Chatelain, et al.
The Journal of Clinical Endocrinology and Metabolism|November 10, 2001
Healthcare consumption decreases in parallel with improvements in quality of life during GH replacement in hypopituitary adults with GH deficiencyE Hernberg-Ståhl, A Luger, R Abs, et al.
Acta Paediatrica Scandinavica. Supplement|January 1, 1988
Recombinant somatropin in treatment of growth hormone deficient children in Sweden and FinlandK Albertsson-Wikland, S Aronson, K O Nilsson, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 24, 2001
The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density. C Wüster, R Abs, B A Bengtsson, et al.
Annals of Internal Medicine|October 15, 1988
Distinguishing benign from malignant euadrenal massesM D Gross, B Shapiro, J A Bouffard, et al.
The Journal of Clinical Endocrinology and Metabolism|November 24, 1999
The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults. KIMS Study Group and the KIMS International BoardB A Bengtsson, R Abs, H Bennmarker, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1987
Functional and scintigraphic evaluation of the silent adrenal massM D Gross, G P Wilton, B Shapiro, et al.
Rheumatology International|July 3, 2014
Erratum to: The effects of an oral preparation containing hyaluronic acid (Oralvisc(®)) on obese knee osteoarthritis patients determined by pain, function, bradykinin, leptin, inflammatory cytokines, and heavy water analysesF R Nelson, R A Zvirbulis, B Zonca, et al.
Rheumatology International|June 6, 2014
The effects of an oral preparation containing hyaluronic acid (Oralvisc®) on obese knee osteoarthritis patients determined by pain, function, bradykinin, leptin, inflammatory cytokines, and heavy water analysesF R Nelson, R A Zvirbulis, B Zonca, et al.
Clinical Endocrinology|September 6, 2000
Growth hormone deficiency and replacement in elderly hypopituitary adults. KIMS Study Group and the KIMS International Board. Pharmacia and Upjohn International Metabolic DatabaseJ P Monson, R Abs, B A Bengtsson, et al.
Pageof 11